Sensei Biotherapeutics, Inc. lost $16.72 per diluted share in fiscal year 2025. This represents an increase of 30.4% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Sensei Biotherapeutics, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$16.72
YoY+30.4%
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
SNSE EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Sensei Biotherapeutics, Inc.'s diluted earnings per share in fiscal year 2025?
Sensei Biotherapeutics, Inc. lost $16.72 per diluted share in fiscal year 2025.
How fast is Sensei Biotherapeutics, Inc.'s diluted earnings per share growing?
Sensei Biotherapeutics, Inc. (SNSE) diluted earnings per share rose by 30.4% year over year, from -$24.01 to -$16.72 in fiscal year 2025.
What was Sensei Biotherapeutics, Inc.'s diluted earnings per share in the most recent quarter?
Sensei Biotherapeutics, Inc. (SNSE) reported -$131.45 in diluted earnings per share in Q1 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Sensei Biotherapeutics, Inc. (SNSE) reported on that line in every period on record.
